• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Spironolactone use associated with improved outcomes for patients with HFpEF and resistant hypertension

byBrian DoughertyandAlex Chan
December 2, 2020
in Cardiology, Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Empagliflozin use is associated with slower progression of chronic kidney disease

Clinical decision-making strategy improves acute heart failure outcomes

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

1. Among patients with HFpEF and resistant hypertension, administration of spironolactone was associated with a reduced risk of composite cardiovascular events, all-cause mortality, and hospitalization for heart failure.

Evidence Level Rating: 2 (Good)

Heart failure with preserved ejection fraction (HFpEF) and resistant hypertension, a salt-retaining condition secondary to inappropriate aldosterone secretion, commonly co-occur, complicating medical management. This study represents a secondary analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) study, a randomized study from 2014 demonstrating that spironolactone, an aldosterone antagonist commonly used in the management of heart failure, does not have a mortality benefit for patients with HFpEF. The aim of this current analysis was to assess whether spironolactone use leads to improved outcomes among patients specifically with HFpEF and concomitant resistant hypertension. The primary outcome was a composite of cardiovascular death, aborted cardiac arrest, and hospitalization for heart failure. From the original TOPCAT cohort, 3,146 patients had HFpEF and hypertension, of whom 1,004 had HFpEF and resistant hypertension (median [IQR] age = 69 [61-76] years, 51.9% female). The risk of the primary outcome among patients with HFpEF and resistant hypertension was significantly lower in the spironolactone group than in the placebo group (HR 0.70, 95% CI 0.53 to 0.91, p = 0.009). However, the risk of the primary outcome among patients with HFpEF without resistant hypertension was not significantly different between the spironolactone and control groups (HR 1.00, 95% CI 0.83 to 1.20, p = 0.97). With regards to specific outcomes, the risk of all-cause mortality and hospitalization for heart failure was significantly lower in the spironolactone group for patients with HFpEF and resistant hypertension, but not for those without resistant hypertension. These data suggest that spironolactone may be an appropriate add-on medication for patients with HFpEF and resistant hypertension already taking ACEIs/ARBs, CCBs, and diuretics.

Click to read the study in JAHA

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiologyhfpef
Previous Post

#VisualAbstract: Golimumab effective at preserving insulin production in type 1 diabetes

Next Post

#VisualAbstract: Evaluation of adjuvant treatments for T1 N0 M0 triple-negative breast cancer

RelatedReports

Fish oil and aspirin did not reduce arteriovenous fistula failure: The FAVOURED trail
Cardiology

Empagliflozin use is associated with slower progression of chronic kidney disease

January 26, 2023
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Clinical decision-making strategy improves acute heart failure outcomes

January 12, 2023
Pediatric DKA associated with recent acute care visits
Cardiology

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

January 11, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

January 11, 2023
Next Post
#VisualAbstract: Evaluation of adjuvant treatments for T1 N0 M0 triple-negative breast cancer

#VisualAbstract: Evaluation of adjuvant treatments for T1 N0 M0 triple-negative breast cancer

#VisualAbstract: Effectiveness of lorlatinib in advanced anaplastic lymphoma kinase-positive lung cancer

#VisualAbstract: Rivaroxaban noninferior to warfarin in patients with atrial fibrillation and bioprosthetic mitral valves

Beta-blockers associated with worse outcomes in non-cardiac perioperative settings

Perioperative anticoagulation post robot-assisted radical prostatectomy not associated with increased high-grade bleeding risk

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
  • Plant-based diets may be associated with lower risk of aggressive prostate cancer
  • #VisualAbstract: Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options